aluates Reports

$ 0.0

Automative

Global Testosterone Blocker Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-14X13081

Global Testosterone Blocker Market Research Report 2023

BUY CHAPTERS

Global Testosterone Blocker Market Research Report 2025

Code: QYRE-Auto-14X13081

Report

May 2025

Pages:82

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Johnson & Johnson

Astellas

Merck

Sanofi

Orion Corporation

Hengrui

Bayer

Schering Plough

Hinova Pharma

Jiangsu Hengrui Pharmaceuticals

Astrazeneca plc

Testosterone Blocker Market Size

The global market for Testosterone Blocker was valued at US$ 3611 million in the year 2024 and is projected to reach a revised size of US$ 5124 million by 2031, growing at a CAGR of 5.2% during the forecast period.

Testosterone Blocker Market

Testosterone blockers, also known as anti-androgen drugs, are used to block the masculinizing effects of testosterone in transgender women. Aldactone (spironolactone) is most commonly used, but other drugs like Propecia (finasteride), Avodart (dutasteride), and Eulexin (flutamide) may also be prescribed.

Drivers of the Testosterone Blocker Market

Increasing prevalence of prostate cancer: Prostate cancer is the most common cancer among men in the United States. Testosterone is a key driver of prostate cancer growth, and testosterone blockers are used to treat the disease.

Rising transgender population: The transgender population is growing rapidly, and testosterone blockers are used to help transgender individuals transition from male to female.

Female hirsutism: Hirsutism is a condition in which women have excessive hair growth on their face, chest, and back. Testosterone blockers can be used to treat hirsutism.

Challenges to the Testosterone Blocker Market

Side effects: Testosterone blockers can have a number of side effects, including hot flashes, fatigue, weight gain, and mood swings. These side effects can discourage some people from using testosterone blockers.

Cost: Testosterone blockers can be expensive, and insurance coverage for these drugs is not always available.

Regulatory hurdles: Testosterone blockers are regulated by the FDA, and the approval process for new drugs can be lengthy and expensive.

This report aims to provide a comprehensive presentation of the global market for Testosterone Blocker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Testosterone Blocker.

The Testosterone Blocker market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Testosterone Blocker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Testosterone Blocker companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Testosterone Blocker Market Report

Report Metric	Details
Report Name	Testosterone Blocker Market
Accounted market size in year	US$ 3611 million
Forecasted market size in 2031	US$ 5124 million
CAGR	5.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Steroidal Testosterone Blocker Nonsteroidal Testosterone Blocker
Segment by Application	Prostate Cancer Benign Prostatic Hyperplasia Polycystic Ovary Syndrome (POCS) Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Johnson & Johnson, AstraZeneca, Astellas, Merck, Sanofi, Orion Corporation, Hengrui, Bayer, Schering-Plough, Hinova Pharma, Jiangsu Hengrui Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Testosterone Blocker company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Testosterone Blocker Market growing?

Ans: The Testosterone Blocker Market witnessing a CAGR of 5.2% during the forecast period 2025-2031.

What is the Testosterone Blocker Market size in 2031?

Ans: The Testosterone Blocker Market size in 2031 will be US$ 5124 million.

Who are the main players in the Testosterone Blocker Market report?

Ans: The main players in the Testosterone Blocker Market are Pfizer, Johnson & Johnson, AstraZeneca, Astellas, Merck, Sanofi, Orion Corporation, Hengrui, Bayer, Schering-Plough, Hinova Pharma, Jiangsu Hengrui Pharmaceuticals

What are the Application segmentation covered in the Testosterone Blocker Market report?

Ans: The Applications covered in the Testosterone Blocker Market report are Prostate Cancer, Benign Prostatic Hyperplasia, Polycystic Ovary Syndrome (POCS), Others

What are the Type segmentation covered in the Testosterone Blocker Market report?

Ans: The Types covered in the Testosterone Blocker Market report are Steroidal Testosterone Blocker, Nonsteroidal Testosterone Blocker

Recommended Reports

Prostate Cancer Therapy

Antiandrogen & Hormone

Hair & Menopause Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Testosterone Blocker Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Steroidal Testosterone Blocker

1.2.3 Nonsteroidal Testosterone Blocker

1.3 Market by Application

1.3.1 Global Testosterone Blocker Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Prostate Cancer

1.3.3 Benign Prostatic Hyperplasia

1.3.4 Polycystic Ovary Syndrome (POCS)

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Testosterone Blocker Market Perspective (2020-2031)

2.2 Global Testosterone Blocker Growth Trends by Region

2.2.1 Global Testosterone Blocker Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Testosterone Blocker Historic Market Size by Region (2020-2025)

2.2.3 Testosterone Blocker Forecasted Market Size by Region (2026-2031)

2.3 Testosterone Blocker Market Dynamics

2.3.1 Testosterone Blocker Industry Trends

2.3.2 Testosterone Blocker Market Drivers

2.3.3 Testosterone Blocker Market Challenges

2.3.4 Testosterone Blocker Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Testosterone Blocker Players by Revenue

3.1.1 Global Top Testosterone Blocker Players by Revenue (2020-2025)

3.1.2 Global Testosterone Blocker Revenue Market Share by Players (2020-2025)

3.2 Global Testosterone Blocker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Testosterone Blocker Revenue

3.4 Global Testosterone Blocker Market Concentration Ratio

3.4.1 Global Testosterone Blocker Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Testosterone Blocker Revenue in 2024

3.5 Global Key Players of Testosterone Blocker Head office and Area Served

3.6 Global Key Players of Testosterone Blocker, Product and Application

3.7 Global Key Players of Testosterone Blocker, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Testosterone Blocker Breakdown Data by Type

4.1 Global Testosterone Blocker Historic Market Size by Type (2020-2025)

4.2 Global Testosterone Blocker Forecasted Market Size by Type (2026-2031)

5 Testosterone Blocker Breakdown Data by Application

5.1 Global Testosterone Blocker Historic Market Size by Application (2020-2025)

5.2 Global Testosterone Blocker Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Testosterone Blocker Market Size (2020-2031)

6.2 North America Testosterone Blocker Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Testosterone Blocker Market Size by Country (2020-2025)

6.4 North America Testosterone Blocker Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Testosterone Blocker Market Size (2020-2031)

7.2 Europe Testosterone Blocker Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Testosterone Blocker Market Size by Country (2020-2025)

7.4 Europe Testosterone Blocker Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Testosterone Blocker Market Size (2020-2031)

8.2 Asia-Pacific Testosterone Blocker Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Testosterone Blocker Market Size by Region (2020-2025)

8.4 Asia-Pacific Testosterone Blocker Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Testosterone Blocker Market Size (2020-2031)

9.2 Latin America Testosterone Blocker Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Testosterone Blocker Market Size by Country (2020-2025)

9.4 Latin America Testosterone Blocker Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Testosterone Blocker Market Size (2020-2031)

10.2 Middle East & Africa Testosterone Blocker Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Testosterone Blocker Market Size by Country (2020-2025)

10.4 Middle East & Africa Testosterone Blocker Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Testosterone Blocker Introduction

11.1.4 Pfizer Revenue in Testosterone Blocker Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Details

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Testosterone Blocker Introduction

11.2.4 Johnson & Johnson Revenue in Testosterone Blocker Business (2020-2025)

11.2.5 Johnson & Johnson Recent Development

11.3 AstraZeneca

11.3.1 AstraZeneca Company Details

11.3.2 AstraZeneca Business Overview

11.3.3 AstraZeneca Testosterone Blocker Introduction

11.3.4 AstraZeneca Revenue in Testosterone Blocker Business (2020-2025)

11.3.5 AstraZeneca Recent Development

11.4 Astellas

11.4.1 Astellas Company Details

11.4.2 Astellas Business Overview

11.4.3 Astellas Testosterone Blocker Introduction

11.4.4 Astellas Revenue in Testosterone Blocker Business (2020-2025)

11.4.5 Astellas Recent Development

11.5 Merck

11.5.1 Merck Company Details

11.5.2 Merck Business Overview

11.5.3 Merck Testosterone Blocker Introduction

11.5.4 Merck Revenue in Testosterone Blocker Business (2020-2025)

11.5.5 Merck Recent Development

11.6 Sanofi

11.6.1 Sanofi Company Details

11.6.2 Sanofi Business Overview

11.6.3 Sanofi Testosterone Blocker Introduction

11.6.4 Sanofi Revenue in Testosterone Blocker Business (2020-2025)

11.6.5 Sanofi Recent Development

11.7 Orion Corporation

11.7.1 Orion Corporation Company Details

11.7.2 Orion Corporation Business Overview

11.7.3 Orion Corporation Testosterone Blocker Introduction

11.7.4 Orion Corporation Revenue in Testosterone Blocker Business (2020-2025)

11.7.5 Orion Corporation Recent Development

11.8 Hengrui

11.8.1 Hengrui Company Details

11.8.2 Hengrui Business Overview

11.8.3 Hengrui Testosterone Blocker Introduction

11.8.4 Hengrui Revenue in Testosterone Blocker Business (2020-2025)

11.8.5 Hengrui Recent Development

11.9 Bayer

11.9.1 Bayer Company Details

11.9.2 Bayer Business Overview

11.9.3 Bayer Testosterone Blocker Introduction

11.9.4 Bayer Revenue in Testosterone Blocker Business (2020-2025)

11.9.5 Bayer Recent Development

11.10 Schering-Plough

11.10.1 Schering-Plough Company Details

11.10.2 Schering-Plough Business Overview

11.10.3 Schering-Plough Testosterone Blocker Introduction

11.10.4 Schering-Plough Revenue in Testosterone Blocker Business (2020-2025)

11.10.5 Schering-Plough Recent Development

11.11 Hinova Pharma

11.11.1 Hinova Pharma Company Details

11.11.2 Hinova Pharma Business Overview

11.11.3 Hinova Pharma Testosterone Blocker Introduction

11.11.4 Hinova Pharma Revenue in Testosterone Blocker Business (2020-2025)

11.11.5 Hinova Pharma Recent Development

11.12 Jiangsu Hengrui Pharmaceuticals

11.12.1 Jiangsu Hengrui Pharmaceuticals Company Details

11.12.2 Jiangsu Hengrui Pharmaceuticals Business Overview

11.12.3 Jiangsu Hengrui Pharmaceuticals Testosterone Blocker Introduction

11.12.4 Jiangsu Hengrui Pharmaceuticals Revenue in Testosterone Blocker Business (2020-2025)

11.12.5 Jiangsu Hengrui Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Johnson & Johnson

Astellas

Merck

Sanofi

Orion Corporation

Hengrui

Bayer

Schering Plough

Hinova Pharma

Jiangsu Hengrui Pharmaceuticals

Astrazeneca plc

List of Tables

Table 1. Global Testosterone Blocker Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Steroidal Testosterone Blocker

Table 3. Key Players of Nonsteroidal Testosterone Blocker

Table 4. Global Testosterone Blocker Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Testosterone Blocker Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Testosterone Blocker Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Testosterone Blocker Market Share by Region (2020-2025)

Table 8. Global Testosterone Blocker Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Testosterone Blocker Market Share by Region (2026-2031)

Table 10. Testosterone Blocker Market Trends

Table 11. Testosterone Blocker Market Drivers

Table 12. Testosterone Blocker Market Challenges

Table 13. Testosterone Blocker Market Restraints

Table 14. Global Testosterone Blocker Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Testosterone Blocker Market Share by Players (2020-2025)

Table 16. Global Top Testosterone Blocker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Testosterone Blocker as of 2024)

Table 17. Ranking of Global Top Testosterone Blocker Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Testosterone Blocker Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Testosterone Blocker, Headquarters and Area Served

Table 20. Global Key Players of Testosterone Blocker, Product and Application

Table 21. Global Key Players of Testosterone Blocker, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Testosterone Blocker Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Testosterone Blocker Revenue Market Share by Type (2020-2025)

Table 25. Global Testosterone Blocker Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Testosterone Blocker Revenue Market Share by Type (2026-2031)

Table 27. Global Testosterone Blocker Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Testosterone Blocker Revenue Market Share by Application (2020-2025)

Table 29. Global Testosterone Blocker Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Testosterone Blocker Revenue Market Share by Application (2026-2031)

Table 31. North America Testosterone Blocker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Testosterone Blocker Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Testosterone Blocker Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Testosterone Blocker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Testosterone Blocker Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Testosterone Blocker Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Testosterone Blocker Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Testosterone Blocker Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Testosterone Blocker Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Testosterone Blocker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Testosterone Blocker Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Testosterone Blocker Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Testosterone Blocker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Testosterone Blocker Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Testosterone Blocker Market Size by Country (2026-2031) & (US$ Million)

Table 46. Pfizer Company Details

Table 47. Pfizer Business Overview

Table 48. Pfizer Testosterone Blocker Product

Table 49. Pfizer Revenue in Testosterone Blocker Business (2020-2025) & (US$ Million)

Table 50. Pfizer Recent Development

Table 51. Johnson & Johnson Company Details

Table 52. Johnson & Johnson Business Overview

Table 53. Johnson & Johnson Testosterone Blocker Product

Table 54. Johnson & Johnson Revenue in Testosterone Blocker Business (2020-2025) & (US$ Million)

Table 55. Johnson & Johnson Recent Development

Table 56. AstraZeneca Company Details

Table 57. AstraZeneca Business Overview

Table 58. AstraZeneca Testosterone Blocker Product

Table 59. AstraZeneca Revenue in Testosterone Blocker Business (2020-2025) & (US$ Million)

Table 60. AstraZeneca Recent Development

Table 61. Astellas Company Details

Table 62. Astellas Business Overview

Table 63. Astellas Testosterone Blocker Product

Table 64. Astellas Revenue in Testosterone Blocker Business (2020-2025) & (US$ Million)

Table 65. Astellas Recent Development

Table 66. Merck Company Details

Table 67. Merck Business Overview

Table 68. Merck Testosterone Blocker Product

Table 69. Merck Revenue in Testosterone Blocker Business (2020-2025) & (US$ Million)

Table 70. Merck Recent Development

Table 71. Sanofi Company Details

Table 72. Sanofi Business Overview

Table 73. Sanofi Testosterone Blocker Product

Table 74. Sanofi Revenue in Testosterone Blocker Business (2020-2025) & (US$ Million)

Table 75. Sanofi Recent Development

Table 76. Orion Corporation Company Details

Table 77. Orion Corporation Business Overview

Table 78. Orion Corporation Testosterone Blocker Product

Table 79. Orion Corporation Revenue in Testosterone Blocker Business (2020-2025) & (US$ Million)

Table 80. Orion Corporation Recent Development

Table 81. Hengrui Company Details

Table 82. Hengrui Business Overview

Table 83. Hengrui Testosterone Blocker Product

Table 84. Hengrui Revenue in Testosterone Blocker Business (2020-2025) & (US$ Million)

Table 85. Hengrui Recent Development

Table 86. Bayer Company Details

Table 87. Bayer Business Overview

Table 88. Bayer Testosterone Blocker Product

Table 89. Bayer Revenue in Testosterone Blocker Business (2020-2025) & (US$ Million)

Table 90. Bayer Recent Development

Table 91. Schering-Plough Company Details

Table 92. Schering-Plough Business Overview

Table 93. Schering-Plough Testosterone Blocker Product

Table 94. Schering-Plough Revenue in Testosterone Blocker Business (2020-2025) & (US$ Million)

Table 95. Schering-Plough Recent Development

Table 96. Hinova Pharma Company Details

Table 97. Hinova Pharma Business Overview

Table 98. Hinova Pharma Testosterone Blocker Product

Table 99. Hinova Pharma Revenue in Testosterone Blocker Business (2020-2025) & (US$ Million)

Table 100. Hinova Pharma Recent Development

Table 101. Jiangsu Hengrui Pharmaceuticals Company Details

Table 102. Jiangsu Hengrui Pharmaceuticals Business Overview

Table 103. Jiangsu Hengrui Pharmaceuticals Testosterone Blocker Product

Table 104. Jiangsu Hengrui Pharmaceuticals Revenue in Testosterone Blocker Business (2020-2025) & (US$ Million)

Table 105. Jiangsu Hengrui Pharmaceuticals Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. Testosterone Blocker Picture

Figure 2. Global Testosterone Blocker Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Testosterone Blocker Market Share by Type: 2024 VS 2031

Figure 4. Steroidal Testosterone Blocker Features

Figure 5. Nonsteroidal Testosterone Blocker Features

Figure 6. Global Testosterone Blocker Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Testosterone Blocker Market Share by Application: 2024 VS 2031

Figure 8. Prostate Cancer Case Studies

Figure 9. Benign Prostatic Hyperplasia Case Studies

Figure 10. Polycystic Ovary Syndrome (POCS) Case Studies

Figure 11. Others Case Studies

Figure 12. Testosterone Blocker Report Years Considered

Figure 13. Global Testosterone Blocker Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Testosterone Blocker Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Testosterone Blocker Market Share by Region: 2024 VS 2031

Figure 16. Global Testosterone Blocker Market Share by Players in 2024

Figure 17. Global Top Testosterone Blocker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Testosterone Blocker as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Testosterone Blocker Revenue in 2024

Figure 19. North America Testosterone Blocker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Testosterone Blocker Market Share by Country (2020-2031)

Figure 21. United States Testosterone Blocker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Testosterone Blocker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Testosterone Blocker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Testosterone Blocker Market Share by Country (2020-2031)

Figure 25. Germany Testosterone Blocker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Testosterone Blocker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Testosterone Blocker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Testosterone Blocker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Testosterone Blocker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Testosterone Blocker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Testosterone Blocker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Testosterone Blocker Market Share by Region (2020-2031)

Figure 33. China Testosterone Blocker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Testosterone Blocker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Testosterone Blocker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Testosterone Blocker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Testosterone Blocker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Testosterone Blocker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Testosterone Blocker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Testosterone Blocker Market Share by Country (2020-2031)

Figure 41. Mexico Testosterone Blocker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Testosterone Blocker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Testosterone Blocker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Testosterone Blocker Market Share by Country (2020-2031)

Figure 45. Turkey Testosterone Blocker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Testosterone Blocker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Testosterone Blocker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Pfizer Revenue Growth Rate in Testosterone Blocker Business (2020-2025)

Figure 49. Johnson & Johnson Revenue Growth Rate in Testosterone Blocker Business (2020-2025)

Figure 50. AstraZeneca Revenue Growth Rate in Testosterone Blocker Business (2020-2025)

Figure 51. Astellas Revenue Growth Rate in Testosterone Blocker Business (2020-2025)

Figure 52. Merck Revenue Growth Rate in Testosterone Blocker Business (2020-2025)

Figure 53. Sanofi Revenue Growth Rate in Testosterone Blocker Business (2020-2025)

Figure 54. Orion Corporation Revenue Growth Rate in Testosterone Blocker Business (2020-2025)

Figure 55. Hengrui Revenue Growth Rate in Testosterone Blocker Business (2020-2025)

Figure 56. Bayer Revenue Growth Rate in Testosterone Blocker Business (2020-2025)

Figure 57. Schering-Plough Revenue Growth Rate in Testosterone Blocker Business (2020-2025)

Figure 58. Hinova Pharma Revenue Growth Rate in Testosterone Blocker Business (2020-2025)

Figure 59. Jiangsu Hengrui Pharmaceuticals Revenue Growth Rate in Testosterone Blocker Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Androgen Suppression Therapy Market Insights Forecast to 2030

Global Testosterone Enanthate Market Research Report 2024

Global Aromatase Inhibitors Market Research Report 2024

Global Estrogen Blocker Market Research Report 2025

Testosterone Cypionate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hypogonadism Drug Market Research Report 2025

Global Oral Testosterone Market Research Report 2025

Global Finasteride Oral Route Market Research Report 2024

Finasteride Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Testosterone Undecanoate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Androgen Receptor AR Antagonist Market Research Report 2024

Global Spironolactone Drugs Market Research Report 2024

Global Tamoxifen Drugs Market Research Report 2024

Testosterone Gel Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Testosterone Hormone Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Finasteride Oral Tablet Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Enzalutamide Tablets Market Research Report 2024

Global Breast Cancer Therapeutics Drugs Market Research Report 2024

Global Tamoxifen Citrate Drugs Market Research Report 2024

RELATED REPORTS

Global Testicular Cancer Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26B6701

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Prostate Cancer Biomarker Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-12M6232

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Benign Prostatic Hyperplasia Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-39G5907

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Prostate Cancer Treatment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-7B2445

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions